Examkin

Soru

Zorluk: Çok zorBreast Disorders

Match each clinical and histopathological description of a breast lesion with its most appropriate definitive management or critical diagnostic association.

  • A 45-year-old woman undergoes core needle biopsy for architectural distortion. Pathology reveals a monomorphic epithelial proliferation partially filling the involved ducts (atypical ductal hyperplasia).Surgical excisional biopsy is mandated due to a substantial risk of concurrent in situ or invasive malignancy in the immediately adjacent tissue.
  • A 38-year-old woman has a core biopsy of a rapidly enlarging 6-cm mass. Pathology shows a biphasic fibroepithelial proliferation with marked stromal overgrowth, nuclear atypia, and high mitotic activity.Definitive management consists of wide local excision with at least 1-cm margins; routine axillary lymph node staging is unnecessary.
  • A 52-year-old woman presents with rapid-onset diffuse breast erythema and skin dimpling. A skin punch biopsy demonstrates tumor emboli completely occluding the dermal lymphatic channels.Standard of care requires initiation of neoadjuvant systemic chemotherapy prior to definitive surgical resection.
  • A 60-year-old woman presents with a unilateral eczematous nipple lesion unresponsive to topical steroids. Biopsy of the nipple epidermis reveals large, atypical cells with abundant pale cytoplasm.Requires comprehensive breast imaging and workup, as it is almost universally associated with an underlying intra-mammary malignancy.
  • A 50-year-old woman has a core biopsy for grouped microcalcifications. Pathology demonstrates discohesive cells completely filling the lobular acini (classic lobular carcinoma in situ, concordant with imaging).Managed primarily as a bilateral risk marker; standard care involves high-risk surveillance and consideration of endocrine risk-reduction therapy.

Cevap

Atypical Ductal Hyperplasia requires excisional biopsy. Phyllodes tumor requires wide local excision with >1cm margins. Inflammatory Breast Cancer requires neoadjuvant chemotherapy. Paget disease of the breast requires evaluation for an underlying malignancy. Classic Lobular Carcinoma In Situ is managed with high-risk surveillance and chemoprevention.
Each specific breast pathology has a uniquely tailored management pathway based on its biological behavior. ADH is high-risk for concurrent malignancy and needs excision. Phyllodes tumors recur locally and spread hematogenously, needing wide margins but not axillary staging. IBC is locally advanced and requires upfront systemic therapy. Paget disease is an indicator of deeper malignancy. Classic LCIS is a bilateral risk marker requiring surveillance rather than localized excision.

Adım Adım Çözüm

1
Evaluate the patient with atypical ductal hyperplasia (ADH) on core biopsy.
Match ADH with the need for surgical excisional biopsy.
Core needle biopsy samples only a small portion of the lesion; ADH has a high rate of upstaging to DCIS or invasive carcinoma, so the entire abnormality must be excised for full histologic evaluation.
2
Evaluate the patient with a rapidly enlarging fibroepithelial lesion showing stromal atypia.
Identify as a phyllodes tumor and match with wide local excision (>1 cm margins).
Phyllodes tumors have a high local recurrence rate if excised with positive margins. They spread via hematogenous routes, making axillary staging unnecessary unless nodes are clinically palpable.
3
Evaluate the patient with dermal lymphatic invasion by tumor cells and skin dimpling.
Identify as inflammatory breast cancer (IBC) and match with neoadjuvant chemotherapy.
IBC is an aggressive, locally advanced cancer. Primary surgery is contraindicated due to a high likelihood of positive margins; therapy must begin with systemic chemotherapy.
4
Evaluate the patient with large clear cells in the nipple epidermis.
Identify as Paget disease of the breast and match with the need for comprehensive imaging.
Paget cells represent intraepidermal spread of malignant cells from deeper within the breast parenchyma; the vast majority of these patients have an underlying underlying DCIS or invasive cancer.
5
Evaluate the patient with classic lobular carcinoma in situ (LCIS) that is concordant with imaging.
Match with high-risk surveillance and endocrine risk-reduction therapy.
Unlike DCIS, classic LCIS is a marker of increased risk for developing cancer in either breast. If concordant with imaging, it does not mandate surgical excision.

Anahtar Kavram

Management of high-risk breast lesions and unique breast malignancies requires specific, evidence-based approaches that differ significantly from standard invasive ductal carcinoma.
Tahmini Süre:2m 30s
Bu soruyu puanla

Konular

Breast Disorders

Bu konudan daha fazla soru